Why the study?
Do hemostatic and fibrinolytic risk factors correlate with the morphological extent and severity of coronary artery disease in patients with type 2 diabetes mellitus?
Do hemostatic and fibrinolytic risk factors correlate with the morphological extent and severity of coronary artery disease in patients with type 2 diabetes mellitus?
In patients with coronary artery disease, type 2 diabetes is associated with more severe and distally pronounced atherosclerosis, which correlates with prothrombotic alterations in hemostatic and fibrinolytic parameters.
Answers are grounded in this paper and cite their sources.
Type 2 diabetes was associated with more severe distal coronary atherosclerosis; hypothesis-generating for hemostatic correlations and requires prospective validation before practice implications.
The influence hemostatitc parameters on the morphological extent and severity of coronary artery disease were studied in patients with and without DM type 2. It is known that patients with diabetes (DM) have abnormal metabolic and hemostatic parameters Of 150 consecutive patients with angiographically proven coronary artery disease 29 presented with DM. Additionally to parameters of lipid-metabolism fibrinogen, tissue-plasminogenactivator (t-PA), plasminogen-activator-inhibitor (PAI), plasmin-a-antiplasmin (PAP), prothrombin-fragment 1+2 (F1+2), thrombin-antithrombin (TAT), von-willebrand-factor (vWF), platelet factor 4 (PF4), glykomembranproteine 140 (GMP140) and the rheologic parameters plasma viscosity and red blood cell aggregation were evaluated. The extent and severity of CAD was evaluated according to the criteria of the American Heart Association. Patients with DM presented with a higher number of conventional risk factors as compared to non-diabetic patients. Additionally there were significant differences for F1+2, red blood cell aggregation and PAI. Diabetic patients showed a more severe extent of coronary arteriosclerosis, which also could be found more distally. A significant relationship between blood-glucose, thrombocyte-activation (vWF), endogenous fibrinolysis (PAI) and the severity of CAD and a more distal location of stenoses could be found (r = 0.6, p < 0.001). Patients with coronary artery disease and DM type 2 showed marked alterations of metabolic, hemostatic, fibrinolytic and rheologic parameters, which can produce a prothrombogenic state. A direct association of thrombogenic factors on coronary morphology could be shown. This can be the pathophysiologic mechanism of more severe and distal pronounced coronary atherosclerosis in these patients.
No takes yet. Share an insight, caveat, or question.
Jax et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: